Prognostic indicators of survival in ALS

Neurology

Volumn 50, Issue 1, 1998, Pages 66-72

  Stambler, Nancy ^a   Charatan, Matthew ^a   Cedarbaum, Jesse M ^a  

^a REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CILIARY NEUROTROPHIC FACTOR;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BODY WEIGHT; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LABORATORY TEST; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; PRIORITY JOURNAL; RESPIRATORY ACIDOSIS; SURVIVAL;

EID: 0031929662     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.1.66     Document Type: Article

References (14)

1. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118:707-719.
2. Ringel SP, Murphy JR, Alderson MK, et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993;43:13161322.
3. Gubbay SS, Kahana E, Zilber N, et al. Amyotrophic lateral sclerosis. A study of its presentation and prognosis. J Neurol 1985;232:295-300.
4. Kondo K, Hemmi I. Clinical statistics in 515 fatal cases of motor neuron disease. Neuroepidemiology 1984;3:129-148.
5. Preux P-M, Couratier PH, Boutros-Toni F, et al. Survival prediction in sporadic amyotrophic lateral sclerosis. Neuroepidemiology 1996;15:153-160.
6. Cedarbaum JM, Stambler N. Performance of the ALS Functional Rating Scale (ALSFRS) in multicenter clinical trials. J Neurol Sci 1997;152(Suppl l):l-9.
7. Bensimon G, Lacomblez L, Meininger, the ALS Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994;330:585-591.
8. Fallat RJ, Jewitt B, Bass M, et al. Spirometry in amyotrophic lateral sclerosis. Arch Neurol 1979;36:74-80.
9. - 9. ALS CNTF Treatment Study (A.C.T.S.) Group. A doubleblind, placebo-controlled clinical trial of subcutaneous recom-binant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis (ALS). Neurology 1996;46:12441249.
10. Andres PL, Hedlund W, Finison L, et al. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology 1986; 36:937-941.
11. Brooks BR. Amyotrophic lateral sclerosis clinimetric scalesguidelines for administration and scoring. In: Herndon R, ed. Handbook of clinical neurologic scales. New York: Demos Vermande, 1997:27-79.
12. Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. Am Rev Respir Dis 1979;119:895-902.
13. Oswald-Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 1995;107:1193-1198.
14. Gold WM. Pulmonary function testing. In: Murray JF, Nadel JA, eds. Respiratory medicine, 2nd ed. Philadelphia: WB Saunders, 1994:871.